NASDAQ:STRO

Sutro Biopharma Stock Forecast

etoro logo Buy STRO
*Your capital is at risk
$23.57
-0.160 (-0.674%)
At Close: Jul 17, 2026
AI Analysis AI Analysis of STRO AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add STRO to Watchlist?
Some Reasons Why To Add STRO:
  • +3,001.3% price growth over the last year
  • High gross margin of 98.7%
  • Strong return on equity of 192.8%
PDF

Sutro Biopharma Inc. stock price ended at $23.57 on Friday, after losing 0.674%
(Updated on Jul 17, 2026)

Sell candidate since Jul 13, 2026 Loss -15.34%

The Sutro Biopharma Inc. stock price fell by -0.674% on the last day (Friday, 17th Jul 2026) from $23.73 to $23.57. It has now fallen 8 days in a row. During the last trading day the stock fluctuated 4.07% from a day low at $23.07 to a day high of $24.01. The price has fallen in 8 of the last 10 days and is down by -22.54% for this period. Volume has increased on the last day by 30 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 328 thousand shares were bought and sold for approximately $7.72 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -24.36% during the next 3 months and, with a 90% probability hold a price between $14.61 and $23.61 at the end of this 3-month period.

STRO Signals & Forecast

There are few to no technical positive signals at the moment. The Sutro Biopharma Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $26.70 and $28.63. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, June 29, 2026, and so far it has fallen -29.33%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Sutro Biopharma Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.94 between high and low, or 4.07%. For the last week, the stock has had daily average volatility of 7.04%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (STRO) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Sutro Biopharma Inc. to open at $23.55, and during the day (based on 14 day Average True Range), to move between $22.32 and $24.82, which gives a possible trading interval of +/-$2.49 (+/-11.16%) up or down from last closing price. If Sutro Biopharma Inc. takes out the full calculated possible swing range there will be an estimated 11.16% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $25.57, some $2.00 (8.49%) from the current price of $23.57, our system finds the risk reward not very attractive.

Is Sutro Biopharma Inc. stock A Buy?

Sutro Biopharma Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -7.401 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 20, 2026 - $23.55 ( 0.0849%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

STRO Performance

Trading levels for STRO

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 24.49 3.90%
R2 24.13 2.38%
R1 23.91 1.44%
Price 23.57
S1 23.19 -1.61%
S2 22.97 -2.55%
S3 22.61 -4.07%

Accumulated Volume Support & Resistance Levels

Level Price
R3 28.41 20.53%
R2 27.38 16.16%
R1 25.57 8.49%
Price 23.57
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Sutro Biopharma Inc. Stock and on which exchange is it traded?
The symbol for Sutro Biopharma Inc. is STRO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Sutro Biopharma Inc. Stock?
Sutro Biopharma Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Sutro Biopharma Inc. Stock?
Sutro Biopharma Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Sutro Biopharma Inc. Stock.

What's the current price of Sutro Biopharma Inc. Stock?
As of the end of day on the Jul 17, 2026, the price of an Sutro Biopharma Inc. (STRO) share was $23.57.

What is the 52-week high and low for Sutro Biopharma Inc. Stock?
The 52-week high for Sutro Biopharma Inc. Stock is $43.85 and the 52-week low is $0.721.

What is the market capitalization of Sutro Biopharma Inc. Stock?
As of the Jul 17, 2026, the market capitalization of Sutro Biopharma Inc. is 228.093M.

When is the next earnings date for Sutro Biopharma Inc.?
The upcoming earnings date for Sutro Biopharma Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT SUTRO BIOPHARMA INC.
Sutro Biopharma
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-H...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
0.578% Jul 13
SRPT
$17.02
1.18% Jun 29
JLL
$299.78
10.30% Jun 24
NMRK
$15.02
3.86% Jun 24
CAG
$13.43
6.29% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE